Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk

Fig. 1

Incidence of delayed CINV. Incidences of delayed CINV were adjusted using IPTW method. Black bars show the 2 antiemetics group, while white bars indicate the 3 antiemetics group. The incidence of delayed vomiting was significantly lower in the 3 antiemetics group than that in the 2 antiemetics group (p < 0.0001)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us